CHOP plus rituximab - Balancing facts and opinion.

被引:30
作者
Cheson, BD [1 ]
机构
[1] NCI, Bethesda, MD 20892 USA
关键词
D O I
10.1056/NEJM200201243460411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:280 / 282
页数:4
相关论文
共 15 条
[1]  
Alas S, 2001, CANCER RES, V61, P5137
[2]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[3]  
Czuczman M, 1999, BLOOD, V94, p99A
[4]   Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].
Czuczman, MS ;
Grillo-López, AJ ;
White, CA ;
Saleh, M ;
Gordon, L ;
LoBuglio, AF ;
Jonas, C ;
Klippenstein, D ;
Dallaire, B ;
Varns, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276
[5]  
Czuczman MS, 2000, BLOOD, V96, p729A
[6]   LONG-TERM FOLLOW-UP OF PATIENTS WITH LOW-GRADE MALIGNANT-LYMPHOMAS TREATED WITH DOXORUBICIN-BASED CHEMOTHERAPY OR CHEMOIMMUNOTHERAPY [J].
DANA, BW ;
DAHLBERG, S ;
NATHWANI, BN ;
CHASE, E ;
COLTMAN, C ;
MILLER, TP ;
FISHER, RI .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :644-651
[7]   COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].
FISHER, RI ;
GAYNOR, ER ;
DAHLBERG, S ;
OKEN, MM ;
GROGAN, TM ;
MIZE, EM ;
GLICK, JH ;
COLTMAN, CA ;
MILLER, TP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006
[8]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[9]  
Greenlee RT, 2001, CA-CANCER J CLIN, V51, P144
[10]   Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas [J].
Kaminski, MS ;
Zelenetz, AD ;
Press, OW ;
Saleh, M ;
Leonard, J ;
Fehrenbacher, L ;
Lister, TA ;
Stagg, RJ ;
Tidmarsh, GF ;
Kroll, S ;
Wahl, RL ;
Knox, SJ ;
Vose, JM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) :3918-3928